Healthy Participant: Clinical Trials

15 trials for Healthy Participant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 10 Phase 1, 3 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 9, Recruiting 1
Not applicable3Active not recruiting 1, Completed 1, Unknown 1
Phase 21Recruiting 1

Follow Healthy Participant: new trials by email Literature Review of Healthy Participant trials Research Report on Healthy Participant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults
prifetrastat Reference, prifetrastat Test 1, prifetrastat Test 2 - Healthy Participant
Phase 1RecruitingPfizer322026-07-142026-07-23
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.
PF-08642534, Itraconazole - Healthy Participant
Phase 1CompletedPfizer142026-05-052026-08-21
A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults
PF-07328948 - Healthy Participant
Phase 1CompletedPfizer102026-03-022026-04-23
A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors
GI-102 in combination with GIB-7, Placebo - Cancer Survivors, Healthy Participant
Phase 2RecruitingGI Innovation, Inc.152026-01-012026-01-26
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
Ibuzatrelvir - Healthy Participant
Phase 1CompletedPfizer122025-10-162026-01-07
A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
PF-07220060 - Healthy Participant
Phase 1CompletedPfizer352025-08-142026-04-20
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
Etrasimod - Healthy Participant
Phase 1CompletedPfizer82025-08-072026-10-20
Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
GST-HG171/Ritonavir, Itraconazole - Healthy Participant
Phase 1CompletedFujian Akeylink Biotechnology Co., Ltd.122023-05-122023-10-17
Effect of Rib Cage and Spine Mobility on Maximum Breath-Hold Time
Spinal mouse (idiag m360), chest circumference measurement, Maximum Breath Hold Test - Healthy Participant
UnknownSaglik Bilimleri Universitesi822022-09-202022-09-02
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants
DNL919, Placebo - Healthy Participant
Phase 1CompletedDenali Therapeutics Inc.472022-07-142023-08-16
Transmission of Covid-19 During Clubbing Events in Closed Places
Club event - Healthy Participant
Not applicableCompletedANRS, Emerging Infectious Diseases12162021-09-042022-04-05
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
PF-07321332/ritonavir, Itraconazole - Healthy Participant
Phase 1CompletedPfizer122021-07-202023-07-13
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
PF-07321332/ritonavir, Carbamazepine, PF 07321332/ritonavir - Healthy Participant
Phase 1CompletedPfizer122021-07-152023-10-10
Laser Etching Effect on Application Mode of Universal Adhesive
Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group), Selective-etch mode with 35% phosphoric acid (K-ETCHANT) (SE-A group), Total-etch mode with Er, Cr: YSGG laser (Waterlase MD) (TE-L group) - Healthy Participant
Not applicableUnknownHacettepe University412019-07-102021-03-26
Different Modes of Universal Adhesive in Smokers and Non-Smokers
G-Premio Bond in etch&rinse mode, G-Premio Bond in selective-etch mode, G-Premio Bond in self-etch mode - Healthy Participant
Not applicableActive not recruitingHacettepe University472018-09-012026-06-26

Narrower conditions

COVID-19 (1)  ·  Smoking (1)

Broader conditions

Behavior (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

Itraconazole (3)  ·  Ritonavir (2)  ·  nirmatrelvir and ritonavir drug combination (2)  ·  4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid (1)  ·  Carbamazepine (1)  ·  etrasimod (1)  ·  phosphoric acid (1)

Sponsors

Pfizer (8)  ·  Hacettepe University (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Denali Therapeutics Inc. (1)  ·  Fujian Akeylink Biotechnology Co., Ltd. (1)  ·  GI Innovation, Inc. (1)  ·  Saglik Bilimleri Universitesi (1)

Countries

Belgium (3)  ·  China (3)  ·  Turkey (Türkiye) (3)  ·  United States (3)  ·  Australia (1)  ·  France (1)  ·  Netherlands (1)

Top investigators

A. Ruya Yazici (2)  ·  Ana-Claire Meyer, MD (1)  ·  Yazdan Yazdanpanah, Pr (1)

Results publications

PMID 36438274, PMID 37795682, PMID 40145953, PMID 42112804, PMID 42698095, PMID 9812178

NIH funding

2025 (1)